Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 2/2016

01.06.2016 | Original Article

Vitamin D Receptor (VDR) Gene Polymorphisms (FokI, BsmI) and their Relation to Vitamin D Status in Pediatrics βeta Thalassemia Major

verfasst von: Shereen Mohamed Elhoseiny, Dalia Saber Morgan, Asmaa Mohamed Rabie, Samer Tharwat Bishay

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Vitamin D is critical for calcium, phosphate homeostasis and for mineralization of the skeleton, especially during periods of rapid growth. Vitamin D Deficiency leads to rickets (in children) and osteomalacia (in adults). Expression and activation of the vitamin D receptor (VDR) are necessary for the effects of vitamin D, in which several single nucleotide polymorphisms have been identified especially (FokI, BsmI). In this study serum 25 (OH) vitamin D3 levels were estimated by Enzyme Linked Immunosorbent Assay [ELISA], VDR (FokI, BsmI) gene polymorphisms were analyzed by polymerase chain reaction-restriction fragment length polymorphism assay [PCR–RFLP].Serum levels of calcium, phosphorus, alkaline phosphatase and ferritin were determined in 50 Pediatrics beta thalassemia major patients and 60 controls. Patients had significantly lower serum calcium (p < 0.001) lower serum vitamin D3 (p < 0.001) with elevated levels of phosphorus (p < 0.001) and alkaline phosphatase than controls (p = 0.04). Of the patients studied, 60 % had vitamin D deficiency (<20 ng/ml), 20 % had vitamin D insufficiency (21–30 ng/ml) and 20 % had sufficient vitamin D status (>30 ng/ml). Patients harboring mutant (Ff,ff) and wild (BB) genotypes were associated with lower serum calcium (p = 0.08, 0.02) respectively, lower vitamin D3 levels (p < 0.001, 0.01) respectively. They were also suffering from more bony complications although the difference was not statistically significant (p > 0.05). In conclusion, these results suggest that the VDR (FokI, BsmI) gene polymorphisms influence vitamin D status, (Ff,ff), BB genotypes had lower vitamin D levels, so they might influence risk of development of bone diseases in beta thalassemia major.
Literatur
1.
Zurück zum Zitat Gaudio A, Morabito N, Xourafa A, Macrì I, Meo A, Morgante S, Trifiletti A, Lasco A, Frisina N (2008) Bisphosphonates in the treatment of thalassemia associated osteoporosis. J Endocrinol Invest 31(2):181–184CrossRefPubMed Gaudio A, Morabito N, Xourafa A, Macrì I, Meo A, Morgante S, Trifiletti A, Lasco A, Frisina N (2008) Bisphosphonates in the treatment of thalassemia associated osteoporosis. J Endocrinol Invest 31(2):181–184CrossRefPubMed
2.
Zurück zum Zitat Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S (2012) Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. Hematology 17(5):291–296CrossRefPubMed Singh K, Kumar R, Shukla A, Phadke SR, Agarwal S (2012) Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. Hematology 17(5):291–296CrossRefPubMed
3.
Zurück zum Zitat Voskaridou E, Terpos E (2004) New insights into the pathophysiology and management of osteoporosis in patients with beta thalassemia. Br J Haematol 127:127–139CrossRefPubMed Voskaridou E, Terpos E (2004) New insights into the pathophysiology and management of osteoporosis in patients with beta thalassemia. Br J Haematol 127:127–139CrossRefPubMed
4.
Zurück zum Zitat Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634–639CrossRefPubMed Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634–639CrossRefPubMed
5.
Zurück zum Zitat Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ (2004) Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 19:1221–1230CrossRefPubMed Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ (2004) Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 19:1221–1230CrossRefPubMed
6.
7.
Zurück zum Zitat Moulas A, Challa N, Chaliasos N, Lapatsanis PD (1997) Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in β-thalassaemia. Acta Paediatr 86:594–599CrossRefPubMed Moulas A, Challa N, Chaliasos N, Lapatsanis PD (1997) Vitamin D metabolites (25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D) and osteocalcin in β-thalassaemia. Acta Paediatr 86:594–599CrossRefPubMed
8.
Zurück zum Zitat Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E et al (2009) Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassemia syndromes in North America. Br J Haematol 146:546–556CrossRefPubMedPubMedCentral Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E et al (2009) Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassemia syndromes in North America. Br J Haematol 146:546–556CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA et al (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187–1193PubMed Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA et al (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187–1193PubMed
10.
Zurück zum Zitat Zintzaras E, Rodopoulou P, Koukoulis GN (2006) BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Dis Markers 22:317–326CrossRefPubMedPubMedCentral Zintzaras E, Rodopoulou P, Koukoulis GN (2006) BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Dis Markers 22:317–326CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Alimirah F, Peng X, Murillo G, Mehta RG (2011) Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS ONE 6:e16024CrossRefPubMedPubMedCentral Alimirah F, Peng X, Murillo G, Mehta RG (2011) Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS ONE 6:e16024CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat World Medical Association. Declaration of Helsinki (2008) Ethical principles for medical research involving human subjects, The 59th WMA General Assembly, Seoul World Medical Association. Declaration of Helsinki (2008) Ethical principles for medical research involving human subjects, The 59th WMA General Assembly, Seoul
14.
Zurück zum Zitat Bowden SA, Robinson RF, Carr R, Mahan JD (2006) Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a paediatric metabolic bone clinic. Pediatrics 121:1585–1590CrossRef Bowden SA, Robinson RF, Carr R, Mahan JD (2006) Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a paediatric metabolic bone clinic. Pediatrics 121:1585–1590CrossRef
15.
Zurück zum Zitat Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z et al (2013) Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and hispanic women. PLoS ONE 8(3):e57967CrossRefPubMedPubMedCentral Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z et al (2013) Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and hispanic women. PLoS ONE 8(3):e57967CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Dawson B, Trapp RG (2001) Basic and clinical biostatistics, 3rd edn. Mcgraw-Hill Inc, New York Dawson B, Trapp RG (2001) Basic and clinical biostatistics, 3rd edn. Mcgraw-Hill Inc, New York
17.
18.
Zurück zum Zitat Dimitriadou M, Christoforidis A, Fidani L, Economou M, Perifanis V, Tsatra L, Katzos G, Metaxa M (2011) FokI gene polymorphism of vitamin D receptor in patients with beta-thalassemia major and its effect on vitamin D status. Hematology 16(1):54–58CrossRefPubMed Dimitriadou M, Christoforidis A, Fidani L, Economou M, Perifanis V, Tsatra L, Katzos G, Metaxa M (2011) FokI gene polymorphism of vitamin D receptor in patients with beta-thalassemia major and its effect on vitamin D status. Hematology 16(1):54–58CrossRefPubMed
19.
Zurück zum Zitat Dimitriadou M, Christoforidis A, Economou M, Teli A, Printza N, Tzimouli V, Tsatra I, Fidani L, Papachristou F, Athanassiou-Metaxa M (2011) FokI polymorphism of vitamin D receptor gene and the presence of renal dysfunction in patients with β-thalassemia major. Pediatr Hematol Oncol 28(6):509–516CrossRefPubMed Dimitriadou M, Christoforidis A, Economou M, Teli A, Printza N, Tzimouli V, Tsatra I, Fidani L, Papachristou F, Athanassiou-Metaxa M (2011) FokI polymorphism of vitamin D receptor gene and the presence of renal dysfunction in patients with β-thalassemia major. Pediatr Hematol Oncol 28(6):509–516CrossRefPubMed
20.
Zurück zum Zitat De Sanctis V, Borsari G, Brachi S, Gubellini E, Gamberini MR, Carandina G (2008) A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparathyroidism. Georgian Med News 156:111–113PubMed De Sanctis V, Borsari G, Brachi S, Gubellini E, Gamberini MR, Carandina G (2008) A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparathyroidism. Georgian Med News 156:111–113PubMed
21.
Zurück zum Zitat Tantawy AA, El Kholy M, Moustafa T, Elsedfy HH (2008) Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol Rev 6(1):132–135PubMed Tantawy AA, El Kholy M, Moustafa T, Elsedfy HH (2008) Bone mineral density and calcium metabolism in adolescents with beta-thalassemia major. Pediatr Endocrinol Rev 6(1):132–135PubMed
22.
Zurück zum Zitat Karimi M, Habibzadeh F, De Sanctis V (2003) Hypoparathyroidism with extensive intracranial calcification in patients with b-thalassemia major. J Pediatr Endocrinol Metab 16:883–886CrossRefPubMed Karimi M, Habibzadeh F, De Sanctis V (2003) Hypoparathyroidism with extensive intracranial calcification in patients with b-thalassemia major. J Pediatr Endocrinol Metab 16:883–886CrossRefPubMed
23.
Zurück zum Zitat Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idel-son M, Goldfarb AW (2000) Bone mineral metabolism in adult with Beta-thalassaemia major and intermedia. Br J Haematol 111:902–907PubMed Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idel-son M, Goldfarb AW (2000) Bone mineral metabolism in adult with Beta-thalassaemia major and intermedia. Br J Haematol 111:902–907PubMed
24.
Zurück zum Zitat El-Edel RH, Ghonaim MM, Abo-Salem OM, El-Nemr FM (2010) Bone mineral density and vitamin D receptor polymorphism in beta-thalassemia major. Pak J Pharm Sci. 23(1):89–96PubMed El-Edel RH, Ghonaim MM, Abo-Salem OM, El-Nemr FM (2010) Bone mineral density and vitamin D receptor polymorphism in beta-thalassemia major. Pak J Pharm Sci. 23(1):89–96PubMed
25.
Zurück zum Zitat Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G (2006) Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 38(6):888–892CrossRefPubMed Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G (2006) Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 38(6):888–892CrossRefPubMed
26.
Zurück zum Zitat Wood JC, Claster S, Carson S, Menteer JD, Hofstra T, Khanna R et al (2008) Vitamin D deficiency, cardiac iron and cardiac function in thalassemia major. Br J Haematol 141:891–894CrossRefPubMedPubMedCentral Wood JC, Claster S, Carson S, Menteer JD, Hofstra T, Khanna R et al (2008) Vitamin D deficiency, cardiac iron and cardiac function in thalassemia major. Br J Haematol 141:891–894CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Chatterton BE, Thomas CM, Schultz CG (2003) Liver density measured by DEXA correlates with serum ferritin in patients with beta-Thalassemia Major. J. Clin Densitom 6(3):283–288CrossRefPubMed Chatterton BE, Thomas CM, Schultz CG (2003) Liver density measured by DEXA correlates with serum ferritin in patients with beta-Thalassemia Major. J. Clin Densitom 6(3):283–288CrossRefPubMed
28.
Zurück zum Zitat Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ et al (2008) Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 88:441–447PubMedPubMedCentral Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ et al (2008) Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 88:441–447PubMedPubMedCentral
29.
Zurück zum Zitat Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10:185–197CrossRefPubMed Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10:185–197CrossRefPubMed
30.
Zurück zum Zitat Deng HW, Shen H, Xu FH et al (2002) Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res 17:678–686CrossRefPubMed Deng HW, Shen H, Xu FH et al (2002) Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res 17:678–686CrossRefPubMed
31.
Zurück zum Zitat Whitfield GK, Remus LS, Jurutka PW, Ziter H, Ak Oza, Ht Dang et al (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177:145–159CrossRefPubMed Whitfield GK, Remus LS, Jurutka PW, Ziter H, Ak Oza, Ht Dang et al (2001) Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177:145–159CrossRefPubMed
32.
Zurück zum Zitat Ferrara M, Matarese SM, Francese M, Borrelli B, Coppola A, Coppola L, Esposito L (2002) Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia. Br J Haematol 117(2):436–440CrossRefPubMed Ferrara M, Matarese SM, Francese M, Borrelli B, Coppola A, Coppola L, Esposito L (2002) Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia. Br J Haematol 117(2):436–440CrossRefPubMed
33.
Zurück zum Zitat Garnero P, Munoz F, Borel O, Sornay-Rendu E, Delmas PD (2005) Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. J Endocrinol Invest 28(4):312–321 Garnero P, Munoz F, Borel O, Sornay-Rendu E, Delmas PD (2005) Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. J Endocrinol Invest 28(4):312–321
34.
Zurück zum Zitat Lorentzon M, Lorentzon R, Nordstrom P (2000) Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy Caucasian men: a cross-sectional and longitudinal study. J Clin Endo Metab 85:1666–1671 Lorentzon M, Lorentzon R, Nordstrom P (2000) Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy Caucasian men: a cross-sectional and longitudinal study. J Clin Endo Metab 85:1666–1671
35.
Zurück zum Zitat Vogiatzi MG, Autio KA, Schneider R, Giardina PJ (2004) Low bone mass in prepubertal children with thalassemia major; insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab 17:1415–1421CrossRefPubMed Vogiatzi MG, Autio KA, Schneider R, Giardina PJ (2004) Low bone mass in prepubertal children with thalassemia major; insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab 17:1415–1421CrossRefPubMed
Metadaten
Titel
Vitamin D Receptor (VDR) Gene Polymorphisms (FokI, BsmI) and their Relation to Vitamin D Status in Pediatrics βeta Thalassemia Major
verfasst von
Shereen Mohamed Elhoseiny
Dalia Saber Morgan
Asmaa Mohamed Rabie
Samer Tharwat Bishay
Publikationsdatum
01.06.2016
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 2/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0552-z

Weitere Artikel der Ausgabe 2/2016

Indian Journal of Hematology and Blood Transfusion 2/2016 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.